Pacira Pharmaceuticals Receives $11.25M Credit Facility from GE Capital

Pacira Pharmaceuticals, Inc., a San Diego, CA-based acute care specialty pharmaceutical company with a primary focus on formulating, developing and manufacturing sustained-release, injectable products, has received an $11.25m credit facility from GE Capital, Healthcare Financial Services.
The financing provides working capital, and facilitates advances toward regulatory approval and preparation for commercialization of Pacira’s EXPAREL™ program.
EXPAREL™ is the company’s bupivacaine-based product administrated by wound infiltration that is designed to deliver extended relief of postoperative pain. 

Join the discussion